The Consistent Egg Labels Act of 2025 requires the Food and Drug Administration to crack down on misleading labeling of egg alternatives and plant-based egg substitutes. The bill defines eggs specifically as the reproductive output of poultry with a calcium-based shell, and prohibits companies from marketing non-egg products using egg-related terms if those products are intended as substitutes for real eggs. The FDA must issue draft guidance within 180 days and final guidance within one year of enactment on how to enforce these labeling rules. Additionally, the FDA and Department of Agriculture must report to Congress within two years on enforcement actions taken, including any warnings or penalties issued against companies selling misbranded egg alternatives. The legislation aims to protect consumers—particularly those with food allergies who rely on clear labeling—and emphasizes eggs' nutritional value as an affordable protein source.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.